169 related articles for article (PubMed ID: 33939327)
1. Model-based evaluation of image-guided fractionated whole-brain radiation therapy in pediatric diffuse intrinsic pontine glioma xenografts.
Husband HR; Campagne O; He C; Zhu X; Bianski BM; Baker SJ; Shelat AA; Tinkle CL; Stewart CF
CPT Pharmacometrics Syst Pharmacol; 2021 Jun; 10(6):599-610. PubMed ID: 33939327
[TBL] [Abstract][Full Text] [Related]
2. Preclinical evaluation of convection-enhanced delivery of liposomal doxorubicin to treat pediatric diffuse intrinsic pontine glioma and thalamic high-grade glioma.
Sewing ACP; Lagerweij T; van Vuurden DG; Meel MH; Veringa SJE; Carcaboso AM; Gaillard PJ; Peter Vandertop W; Wesseling P; Noske D; Kaspers GJL; Hulleman E
J Neurosurg Pediatr; 2017 May; 19(5):518-530. PubMed ID: 28291423
[TBL] [Abstract][Full Text] [Related]
3. Poly-ADP-Ribose Polymerase as a Therapeutic Target in Pediatric Diffuse Intrinsic Pontine Glioma and Pediatric High-Grade Astrocytoma.
Chornenkyy Y; Agnihotri S; Yu M; Buczkowicz P; Rakopoulos P; Golbourn B; Garzia L; Siddaway R; Leung S; Rutka JT; Taylor MD; Dirks PB; Hawkins C
Mol Cancer Ther; 2015 Nov; 14(11):2560-8. PubMed ID: 26351319
[TBL] [Abstract][Full Text] [Related]
4. Survival benefit for patients with diffuse intrinsic pontine glioma (DIPG) undergoing re-irradiation at first progression: A matched-cohort analysis on behalf of the SIOP-E-HGG/DIPG working group.
Janssens GO; Gandola L; Bolle S; Mandeville H; Ramos-Albiac M; van Beek K; Benghiat H; Hoeben B; Morales La Madrid A; Kortmann RD; Hargrave D; Menten J; Pecori E; Biassoni V; von Bueren AO; van Vuurden DG; Massimino M; Sturm D; Peters M; Kramm CM
Eur J Cancer; 2017 Mar; 73():38-47. PubMed ID: 28161497
[TBL] [Abstract][Full Text] [Related]
5. Characterization of Diffuse Intrinsic Pontine Glioma Radiosensitivity using Synchrotron Microbeam Radiotherapy and Conventional Radiation Therapy In Vitro.
Smyth LM; Rogers PAW; Crosbie JC; Donoghue JF
Radiat Res; 2018 Feb; 189(2):146-155. PubMed ID: 29364085
[TBL] [Abstract][Full Text] [Related]
6. Radiation dose response of neurologic symptoms during conformal radiotherapy for diffuse intrinsic pontine glioma.
Tinkle CL; Campbell K; Han Y; Li Y; Bianski B; Broniscer A; Khan RB; Merchant TE
J Neurooncol; 2020 Mar; 147(1):195-203. PubMed ID: 32016716
[TBL] [Abstract][Full Text] [Related]
7. Monitoring of tumor growth and post-irradiation recurrence in a diffuse intrinsic pontine glioma mouse model.
Caretti V; Zondervan I; Meijer DH; Idema S; Vos W; Hamans B; Bugiani M; Hulleman E; Wesseling P; Vandertop WP; Noske DP; Kaspers G; Molthoff CF; Wurdinger T
Brain Pathol; 2011 Jul; 21(4):441-51. PubMed ID: 21159008
[TBL] [Abstract][Full Text] [Related]
8. Hypofractionation vs conventional radiation therapy for newly diagnosed diffuse intrinsic pontine glioma: a matched-cohort analysis.
Janssens GO; Jansen MH; Lauwers SJ; Nowak PJ; Oldenburger FR; Bouffet E; Saran F; Kamphuis-van Ulzen K; van Lindert EJ; Schieving JH; Boterberg T; Kaspers GJ; Span PN; Kaanders JH; Gidding CE; Hargrave D
Int J Radiat Oncol Biol Phys; 2013 Feb; 85(2):315-20. PubMed ID: 22682807
[TBL] [Abstract][Full Text] [Related]
9. Apparent diffusion coefficient histogram metrics correlate with survival in diffuse intrinsic pontine glioma: a report from the Pediatric Brain Tumor Consortium.
Poussaint TY; Vajapeyam S; Ricci KI; Panigrahy A; Kocak M; Kun LE; Boyett JM; Pollack IF; Fouladi M
Neuro Oncol; 2016 May; 18(5):725-34. PubMed ID: 26487690
[TBL] [Abstract][Full Text] [Related]
10. WEE1 kinase inhibition enhances the radiation response of diffuse intrinsic pontine gliomas.
Caretti V; Hiddingh L; Lagerweij T; Schellen P; Koken PW; Hulleman E; van Vuurden DG; Vandertop WP; Kaspers GJ; Noske DP; Wurdinger T
Mol Cancer Ther; 2013 Feb; 12(2):141-50. PubMed ID: 23270927
[TBL] [Abstract][Full Text] [Related]
11. Defining Optimal Target Volumes of Conformal Radiation Therapy for Diffuse Intrinsic Pontine Glioma.
Tinkle CL; Simone B; Chiang J; Li X; Campbell K; Han Y; Li Y; Hover LD; Molitoris JK; Becksfort J; Lucas JT; Patay Z; Baker SJ; Broniscer A; Merchant TE
Int J Radiat Oncol Biol Phys; 2020 Mar; 106(4):838-847. PubMed ID: 31785339
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of mutant PPM1D enhances DNA damage response and growth suppressive effects of ionizing radiation in diffuse intrinsic pontine glioma.
Akamandisa MP; Nie K; Nahta R; Hambardzumyan D; Castellino RC
Neuro Oncol; 2019 Jun; 21(6):786-799. PubMed ID: 30852603
[TBL] [Abstract][Full Text] [Related]
13. Radiation and subsequent reirradiation outcomes in the treatment of diffuse intrinsic pontine glioma and a systematic review of the reirradiation literature.
Freese C; Takiar V; Fouladi M; DeWire M; Breneman J; Pater L
Pract Radiat Oncol; 2017; 7(2):86-92. PubMed ID: 28274399
[TBL] [Abstract][Full Text] [Related]
14. Histone H3F3A and HIST1H3B K27M mutations define two subgroups of diffuse intrinsic pontine gliomas with different prognosis and phenotypes.
Castel D; Philippe C; Calmon R; Le Dret L; Truffaux N; Boddaert N; Pagès M; Taylor KR; Saulnier P; Lacroix L; Mackay A; Jones C; Sainte-Rose C; Blauwblomme T; Andreiuolo F; Puget S; Grill J; Varlet P; Debily MA
Acta Neuropathol; 2015 Dec; 130(6):815-27. PubMed ID: 26399631
[TBL] [Abstract][Full Text] [Related]
15. Reirradiation in patients with diffuse intrinsic pontine gliomas: The Canadian experience.
Lassaletta A; Strother D; Laperriere N; Hukin J; Vanan MI; Goddard K; Lafay-Cousin L; Johnston DL; Zelcer S; Zapotocky M; Rajagopal R; Ramaswamy V; Hawkins C; Tabori U; Huang A; Bartels U; Bouffet E
Pediatr Blood Cancer; 2018 Jun; 65(6):e26988. PubMed ID: 29369515
[TBL] [Abstract][Full Text] [Related]
16. Quantifying radiation therapy response using apparent diffusion coefficient (ADC) parametric mapping of pediatric diffuse intrinsic pontine glioma: a report from the pediatric brain tumor consortium.
Ceschin R; Kocak M; Vajapeyam S; Pollack IF; Onar-Thomas A; Dunkel IJ; Poussaint TY; Panigrahy A
J Neurooncol; 2019 May; 143(1):79-86. PubMed ID: 30810873
[TBL] [Abstract][Full Text] [Related]
17. Mesenchymal Stem Cells Successfully Deliver Oncolytic Virotherapy to Diffuse Intrinsic Pontine Glioma.
Chastkofsky MI; Pituch KC; Katagi H; Zannikou M; Ilut L; Xiao T; Han Y; Sonabend AM; Curiel DT; Bonner ER; Nazarian J; Horbinski CM; James CD; Saratsis AM; Hashizume R; Lesniak MS; Balyasnikova IV
Clin Cancer Res; 2021 Mar; 27(6):1766-1777. PubMed ID: 33272983
[TBL] [Abstract][Full Text] [Related]
18. Pseudoprogression in children, adolescents and young adults with non-brainstem high grade glioma and diffuse intrinsic pontine glioma.
Carceller F; Fowkes LA; Khabra K; Moreno L; Saran F; Burford A; Mackay A; Jones DT; Hovestadt V; Marshall LV; Vaidya S; Mandeville H; Jerome N; Bridges LR; Laxton R; Al-Sarraj S; Pfister SM; Leach MO; Pearson AD; Jones C; Koh DM; Zacharoulis S
J Neurooncol; 2016 Aug; 129(1):109-21. PubMed ID: 27180091
[TBL] [Abstract][Full Text] [Related]
19. Single institution experience in re-irradiation of biopsy-proven diffuse intrinsic pontine gliomas.
Zamora PL; Miller SR; Kovoor JJ
Childs Nerv Syst; 2021 Aug; 37(8):2539-2543. PubMed ID: 33973056
[TBL] [Abstract][Full Text] [Related]
20. Developing chemotherapy for diffuse pontine intrinsic gliomas (DIPG).
Gwak HS; Park HJ
Crit Rev Oncol Hematol; 2017 Dec; 120():111-119. PubMed ID: 29198324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
